PE20081072A1 - Composiciones de anti-histaminicos, descongestivos, antitusivos y drogas anti-inflamatorios no esteroidales - Google Patents

Composiciones de anti-histaminicos, descongestivos, antitusivos y drogas anti-inflamatorios no esteroidales

Info

Publication number
PE20081072A1
PE20081072A1 PE2008000932A PE2008000932A PE20081072A1 PE 20081072 A1 PE20081072 A1 PE 20081072A1 PE 2008000932 A PE2008000932 A PE 2008000932A PE 2008000932 A PE2008000932 A PE 2008000932A PE 20081072 A1 PE20081072 A1 PE 20081072A1
Authority
PE
Peru
Prior art keywords
decongestives
antitusives
histamines
compositions
inflammatory drugs
Prior art date
Application number
PE2008000932A
Other languages
English (en)
Spanish (es)
Inventor
Roger Glen Berlin
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32682029&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20081072(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of PE20081072A1 publication Critical patent/PE20081072A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PE2008000932A 2002-12-18 2004-01-05 Composiciones de anti-histaminicos, descongestivos, antitusivos y drogas anti-inflamatorios no esteroidales PE20081072A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43434202P 2002-12-18 2002-12-18

Publications (1)

Publication Number Publication Date
PE20081072A1 true PE20081072A1 (es) 2008-08-15

Family

ID=32682029

Family Applications (2)

Application Number Title Priority Date Filing Date
PE2008000932A PE20081072A1 (es) 2002-12-18 2004-01-05 Composiciones de anti-histaminicos, descongestivos, antitusivos y drogas anti-inflamatorios no esteroidales
PE2004000029A PE20040973A1 (es) 2002-12-18 2004-01-05 Composiciones de anti-histaminicos, descongestivos y drogas anti-inflamatorias no esteroidales

Family Applications After (1)

Application Number Title Priority Date Filing Date
PE2004000029A PE20040973A1 (es) 2002-12-18 2004-01-05 Composiciones de anti-histaminicos, descongestivos y drogas anti-inflamatorias no esteroidales

Country Status (18)

Country Link
US (1) US7863287B2 (enExample)
EP (1) EP1572206B1 (enExample)
JP (1) JP2006515299A (enExample)
CN (2) CN102406642B (enExample)
AR (1) AR042543A1 (enExample)
AU (1) AU2003301188B2 (enExample)
CA (1) CA2508611C (enExample)
CL (1) CL2003002653A1 (enExample)
CO (1) CO5640087A2 (enExample)
ES (1) ES2468217T3 (enExample)
MX (1) MXPA05006331A (enExample)
NZ (1) NZ540289A (enExample)
PE (2) PE20081072A1 (enExample)
PT (1) PT1572206E (enExample)
RU (1) RU2322262C2 (enExample)
TW (1) TWI313598B (enExample)
WO (1) WO2004056320A2 (enExample)
ZA (1) ZA200504908B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2635313C (en) 2005-12-29 2013-12-31 Osmotica Corp. Triple combination release multi-layered tablet
US20100143471A1 (en) * 2007-03-21 2010-06-10 Lupin Limited Novel reduced dose pharmaceutical compositions of fexofenadine and pseudoephedrine
WO2010056216A1 (en) * 2008-11-11 2010-05-20 Berko Ilac Ve Kimya San.A.S. Pharmaceutical composition comprising ibuprofen, pseudoephedrine and chlorpheniramine
WO2010078541A1 (en) * 2009-01-05 2010-07-08 Mcneil-Ppc, Inc. Tablet containing coated particles of cetirizine, pseudoephedrine, and/or naproxen
US8377475B2 (en) 2009-01-05 2013-02-19 Mcneil-Ppc, Inc. Tablet containing cetirizine, pseudoephedrine, and naproxen containing a barrier layer
CA2748783A1 (en) 2009-01-05 2010-07-08 Mcneil-Ppc, Inc. Three layer tablet containing cetirizine, pseudoephedrine, and naproxen
EP2493465B1 (en) * 2009-10-26 2014-10-22 Sephoris Pharmaceuticals, LLC Treatment of sunburn using analgesics and antihistamines
JP5777906B2 (ja) * 2010-02-26 2015-09-09 興和株式会社 ロキソプロフェン又はその塩含有の医薬組成物
BR112012028153A2 (pt) * 2010-05-03 2018-08-07 Tsh Biopharm Corporation Ltd composição farmacêutica e método para o tratamento de hipertensão
MX2013000703A (es) * 2010-07-19 2014-07-24 Procaps Sa Aparato y proceso para encapsular capsulas u otras formas de dosificacion solidas dentro de capsulas.
JP5898963B2 (ja) * 2011-01-12 2016-04-06 興和株式会社 ロキソプロフェン又はその塩含有の医薬組成物
JP5898964B2 (ja) * 2011-01-12 2016-04-06 興和株式会社 ロキソプロフェン又はその塩を含有する医薬組成物
US9216181B2 (en) * 2011-06-08 2015-12-22 Southwest Research Institute BMP-2 upregulating compounds for healing bone tissue and screening methods for selecting such compounds
US10596261B2 (en) * 2013-03-12 2020-03-24 Hercules Incorporated Coprocessed silica coated polymer composition
EP2965746B1 (en) 2014-07-10 2019-03-13 Santa Farma Ilaç Sanayi A.S. An oral pharmaceutical composition comprising ibuprofen, ibuprofen sodium dihydrate, pseudoephedrine hydrochloride and chlorpheniramine maleate
ES2926494T3 (es) * 2015-03-26 2022-10-26 Sen Jam Pharmaceutical Llc Combinación de naproxeno y fexofenadina para inhibir los síntomas asociados con veisalgia
CN104758935B (zh) * 2015-04-10 2017-11-21 海口世康药物研究有限公司 一种改善复方布洛芬制剂稳定性的组合物及其制备方法
RU2019109695A (ru) 2016-09-26 2020-10-26 Дзе Проктер Энд Гэмбл Компани Лекарственная форма для пролонгированного ослабления симптомов

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4906625A (en) 1984-02-08 1990-03-06 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and metyhods of using same
US4522826A (en) 1984-02-08 1985-06-11 Richardson-Vicks Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
US4683243A (en) 1984-02-08 1987-07-28 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
US4985459A (en) 1984-02-08 1991-01-15 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
US4755532A (en) 1984-02-08 1988-07-05 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
US4585783A (en) 1984-02-08 1986-04-29 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
US5025019A (en) * 1984-04-09 1991-06-18 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US4783465A (en) 1984-04-09 1988-11-08 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
AU738274B2 (en) 1984-04-09 2001-09-13 Procter & Gamble Company, The Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US4552899A (en) 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US4840962A (en) 1984-04-09 1989-06-20 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US4871733A (en) 1984-04-09 1989-10-03 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
IE58110B1 (en) 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US4829064A (en) 1987-06-08 1989-05-09 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US4975426A (en) 1987-06-08 1990-12-04 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US4971785A (en) * 1988-03-14 1990-11-20 Spectrum Consumer Products Co., Inc. Non-alcoholic delivery system for orally ingestible active ingredients
US5288479A (en) 1989-01-17 1994-02-22 Sterling Drug, Inc. Extrudable elastic oral pharmaceutical gel compositions and metered dose dispensers containing them and method of making and method of use thereof
US4990535A (en) 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
US5133974A (en) 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
NZ234143A (en) 1989-06-28 1991-10-25 Mcneil Ppc Inc Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents
JPH06500784A (ja) * 1990-09-11 1994-01-27 リチャードソン、ビックス、インコーポレーテッド 改善された鎮痛効果を与えるための方法
WO1992004022A1 (en) 1990-09-11 1992-03-19 Richardson Vicks Inc. Use of compositions containing 2-(6'-substituted-2'-naphthyl)-acetic acid derivatives for the treatment of respiratory disorders
US5196436A (en) 1990-10-31 1993-03-23 The Procter & Gamble Company Dextromethorphan antitussive compositions
CA2107331A1 (en) 1991-04-01 1992-10-02 Robert T. Sims Ibuprofen-decongestant combinations
SK279279B6 (sk) * 1991-05-13 1998-09-09 The Boots Company Plc S(-)-nátrium-2-(4-izobutylfenyl)propionát-dihydrát
US5492689A (en) 1991-11-19 1996-02-20 The Center For Innovative Technology Combined virustatic antimediator (COVAM) treatment of common colds
CA2084028A1 (en) 1991-11-27 1993-05-28 Harish B. Pandya Hot flu composition
US5968551A (en) 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
US6303632B1 (en) 1992-09-03 2001-10-16 Sepracor Inc. Compositions for treating allergic and other disorders using norastemizole in combination with other active ingredients
WO1994014476A1 (en) 1992-12-21 1994-07-07 The Procter & Gamble Company Use of s(+) antipodes of analgesic agents for the manufacture of a composition to treat respiratory disorders
JPH08504818A (ja) * 1992-12-21 1996-05-28 ザ、プロクター、エンド、ギャンブル、カンパニー カフェインとｓ（＋）‐イブプロフェン、ｓ（＋）‐フルルビプロフェン又はｓ（＋）‐ケトプロフェンを含有した組成物
DK0701434T3 (da) 1993-06-04 2002-11-18 Warner Lambert Co Præparater indeholdende siliciumdioxid til forbedring af deres smag
US5466865A (en) 1993-07-02 1995-11-14 Ibah, Inc. Neomorphic ibuprofen and methods of using same
EP0717624A1 (en) * 1993-09-07 1996-06-26 The Procter & Gamble Company Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine
CA2170488A1 (en) 1993-09-07 1995-03-16 Sekhar Mitra Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive
US5691352A (en) * 1993-10-25 1997-11-25 Merrell Pharmaceuticals Inc. Stable pharmaceutical composition of terfenadine and ibuprofen
US5560913A (en) 1995-01-27 1996-10-01 The Procter & Gamble Company Pharmaceutical compositions
US5622723A (en) 1995-02-03 1997-04-22 Eurand America, Incorporated Procedure for encapsulating chlorpheniramine
CA2227958A1 (en) 1995-07-28 1997-02-13 Sekhar Mitra Compositions containing analgesics and antihistamines and methods for treating respiratory disorders
US5766622A (en) * 1996-08-14 1998-06-16 The Procter & Gamble Company Inhibiting undesirable taste in oral compositions
US6210710B1 (en) 1997-04-28 2001-04-03 Hercules Incorporated Sustained release polymer blend for pharmaceutical applications
US5895663A (en) 1997-07-31 1999-04-20 L. Perrigo Company Pseudoephedrine hydrochloride extended-release tablets
US5869479A (en) 1997-08-14 1999-02-09 Schering Corporation Treatment of upper airway allergic responses
EP1014983A1 (en) 1997-09-19 2000-07-05 The Procter & Gamble Company Naproxen/cetirizine compositions and methods for treating respiratory disorders
US6337091B1 (en) 1997-10-27 2002-01-08 Temple University - Of The Commonwealth System Of Higher Education Matrix for controlled delivery of highly soluble pharmaceutical agents
WO1999021556A1 (en) 1997-10-29 1999-05-06 J-Med Pharmaceuticals, Inc. Antihistamine/decongestant regimens for treating rhinitis
US6090411A (en) 1998-03-09 2000-07-18 Temple University Monolithic tablet for controlled drug release
US6267986B1 (en) 1999-09-24 2001-07-31 Ranbaxy Laboratories Limited Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine
SK287105B6 (sk) 1999-12-20 2009-12-07 Schering Corporation Dvojvrstvový orálny dávkový prostriedok s predĺženým uvoľňovaním
WO2003024427A1 (en) 1999-12-20 2003-03-27 Temple University Of The Commonwealth System Of Higher Education Tableted oral extended release dosage form
JP2002316927A (ja) 2001-04-19 2002-10-31 Taisho Pharmaceut Co Ltd 感冒用組成物
US20040147606A1 (en) 2001-05-25 2004-07-29 Yoichi Onuki Medicinal compositions
AU2003219348A1 (en) 2002-04-22 2003-11-03 Adcock Ingram Intellectual Property (Proprietary) Limited Pharmaceutical compositions comprising a decongenstant and further active ingredients for treating cough and flu
JPWO2004048895A1 (ja) 2002-11-22 2006-03-23 財団法人くまもとテクノ産業財団 移動体ナビゲート情報表示方法および移動体ナビゲート情報表示装置
WO2005063219A2 (en) 2003-12-23 2005-07-14 Ranbaxy Laboratories Limited Ibuprofen-containing soft gelatin capsules

Also Published As

Publication number Publication date
EP1572206A4 (en) 2007-07-18
PT1572206E (pt) 2014-06-12
CN102406642A (zh) 2012-04-11
CL2003002653A1 (es) 2005-04-22
PE20040973A1 (es) 2004-12-14
WO2004056320A2 (en) 2004-07-08
RU2005122403A (ru) 2006-01-20
ES2468217T3 (es) 2014-06-16
CO5640087A2 (es) 2006-05-31
RU2322262C2 (ru) 2008-04-20
TW200413004A (en) 2004-08-01
WO2004056320A3 (en) 2004-09-23
CN1726035A (zh) 2006-01-25
EP1572206A2 (en) 2005-09-14
AU2003301188A1 (en) 2004-07-14
HK1078494A1 (en) 2006-03-17
MXPA05006331A (es) 2005-08-26
CA2508611A1 (en) 2004-07-08
HK1166602A1 (en) 2012-11-02
TWI313598B (en) 2009-08-21
CA2508611C (en) 2011-07-26
US7863287B2 (en) 2011-01-04
ZA200504908B (en) 2006-12-27
JP2006515299A (ja) 2006-05-25
EP1572206B1 (en) 2014-04-23
CN102406642B (zh) 2013-04-03
US20040186184A1 (en) 2004-09-23
AR042543A1 (es) 2005-06-22
AU2003301188B2 (en) 2009-07-02
NZ540289A (en) 2006-10-27

Similar Documents

Publication Publication Date Title
PE20081072A1 (es) Composiciones de anti-histaminicos, descongestivos, antitusivos y drogas anti-inflamatorios no esteroidales
CL2019000209A1 (es) Formulación novedosa administrable por la vía oral.
AR038527A1 (es) Forma de dosificacion que contiene un inhibidor de la pde 4 como ingrediente activo
MX2009004203A (es) Combinaciones de paracetamol/ibuprofeno y metodo para su uso.
ES2916649T1 (es) Composiciones y usos para el tratamiento de la esclerosis múltiple
AR067184A1 (es) Uso de 6-(3-cloro-2-fluorbencil)-1-[(2s)-1-hidroxi-3-metilbutan-2-il]-7-metoxi-4-oxo-1,4-dihidroquinolina-3-carboxilico. composicion farmaceutica
CR9626A (es) Formas de dosificacion de liberacion retardada oral altamente biodisponible de un o-desmetilvenlafaxin succinato
PE20121820A1 (es) (2s,3r)-n-(2-((3-piridinil)metil)-1-azabiciclo[2.2.2]oct-3-il)benzofuran-2-carboxamida, formas de sales novedosas de ella, y metodos de uso de ella
CL2011000798A1 (es) Uso de etexilato de dabigatran o una sal del mismo para preparar un medicamento util para la prevencion del ictus en pacientes que padecen fibrilacion auricular.
CL2019003619A1 (es) Preparación sólida para administración oral.
AR080491A1 (es) Formulaciones orales y sales lipofilicas de metilnaltrexona
CO6321158A2 (es) Formulacion oral
UY27296A1 (es) Composición farmacéutica que contiene mosaprida y pancreatina
CL2009001841A1 (es) Uso de una composición de liberación sostenida de 4-aminopiridina para preparar un medicamento útil para tratar esclerosis multiple en un sujeto.
CL2010000524A1 (es) Uso de una composición tópica que comprende 3,75% de imiquimod y un portador farmacéuticamente aceptable para preparar un medicamento útil para tratar verrugas genitales o perianales.
UY27018A1 (es) Derivados de la pirimidina
AR066924A1 (es) Formulacion de nevirapina de liberacion prolongada
MX2007000117A (es) Una composicion de combinacion.
AR030957A1 (es) Composiciones de analgesico y glucosamina
PA8571901A1 (es) Nueva composicion farmaceutica
PE20010540A1 (es) Composicion de fitoalexinas estilbenicas util para la profilaxis y tratamiento de sintomas asociados con el resfriado y enfermedades similares a la influenza
CL2008000684A1 (es) Composicion farmaceutica que comprende metformina r-(+) lipoato y un inhibidor de reductasa hmg-coa; formulacion de dosis unitaria; y uso en el tratamiento de una complicacion diabetica.
MXPA02010828A (es) Composicion farmaceutica en capsulas que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor.
AR043370A1 (es) Composiciones farmaceuticas de administracion oral y metodos para evitar la interaccion alimento -droga
UY29989A1 (es) Composiciones farmacéuticas de agentes hipnoticos de accion corta en forma de liberación modificada y los procedimientos para preparar dichas formulaciones

Legal Events

Date Code Title Description
FC Refusal